ArticleFrontiers in microbiology2019
Fengycins From
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 91 citations in OpenAlex.
- Role of C17 fengycin B fromApplied and environmental microbiology · 2026Article
- Characterization ofJournal of fungi (Basel, Switzerland) · 2026Article
- Bacillus-derived antimicrobial peptides as alternatives to antibiotics in poultry: mechanisms, applications, and future prospects- a review.Archives of microbiology · 2026Review
- Comparative genomics and biocontrol potential of five Bacillus strains isolated from grapevine rhizosphere.Scientific reports · 2026Article
- Lactic acid bacteria: potentials in canine formulas for puppies.Veterinary research communications · 2025Article
- Identification of an antifungal lipopeptide fromMicrobiology spectrum · 2025Article
- Proposal ofInternational journal of molecular sciences · 2025Article
- Genomic and Functional Characterization of Bacillus siamensis B01 with Antimicrobial Activity Against Vibrio spp.Current microbiology · 2025Article
- Genomic Analysis and Metabolite Profiling of Three ProbioticPreventive nutrition and food science · 2025Article
- Characterization of the antifungal activity of the bacterial isolate Bacillus velezensis TCG15.Archives of microbiology · 2025Article
- Whole genome analysis and biocontrol potential of endophytic Bacillus cereus EMS1 against Fusarium wilt in banana.World journal of microbiology & biotechnology · 2025Article
- Antimicrobial Activity ofInternational journal of molecular sciences · 2025Review
- Whole-Genome Sequencing ofMicroorganisms · 2024Article
- Investigating the antimicrobial and antibiofilm properties of marine halophilic Bacillus species against ESKAPE pathogens.Environmental microbiology reports · 2024Article
- Antifungal potential of lipopeptides produced by theMicrobiology spectrum · 2024Article
- Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.Scientific reports · 2024Article
- Genomic and biological control ofFrontiers in microbiology · 2024Article
- Unraveling the genome of Bacillus velezensis MEPScientific reports · 2023Article
- Biosurfactants: Secondary Metabolites Involved in the Process of Bioremediation and Biofilm Removal.Applied biochemistry and biotechnology · 2023Review
- Lichenysin-like Polypeptide Production byMicroorganisms · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.